Literature DB >> 3655955

The effect of medication compliance on the control of hypertension.

S A Eisen1, R S Woodward, D Miller, E Spitznagel, C A Windham.   

Abstract

The effect of medication-taking patterns on blood pressure was investigated in 24 hypertensive outpatients being treated with once-daily doses of hydrochlorothiazide or chlorthalidone. Medication-taking patterns were measured with a small pill dispenser that electronically records the time of medication removal. Blood pressure reduction was found to correlate better with the total number of doses the patient removed from the pill pack during a month than with any of four other compliance measures that were based on the timing of dose removal. Analysis also suggested that blood pressure is improved if patients ingest omitted doses to "catch up" to the prescribed regimen. It is concluded that a simple pill count may be the most clinically relevant definition of compliance for patients with hypertension being treated with only hydrochlorothiazide or chlorthalidone, and that such patients should ingest all prescribed doses, regardless of the time interval between doses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3655955     DOI: 10.1007/bf02596162

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  23 in total

1.  Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.

Authors: 
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

2.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Medication packaging: simple solutions to nonadherence problems?

Authors:  P Rudd
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

Review 5.  Understanding and improving patient compliance.

Authors:  S A Eraker; J P Kirscht; M H Becker
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

6.  Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Authors:  D L Sackett; R B Haynes; E S Gibson; B C Hackett; D W Taylor; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

7.  Compliance with short-term antimicrobial therapy: some techniques that help.

Authors:  J Lima; L Nazarian; E Charney; C Lahti
Journal:  Pediatrics       Date:  1976-03       Impact factor: 7.124

Review 8.  The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected.

Authors:  W C Roberts
Journal:  Am J Med       Date:  1975-10       Impact factor: 4.965

9.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

10.  Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee.

Authors: 
Journal:  Hypertension       Date:  1985 May-Jun       Impact factor: 10.190

View more
  10 in total

1.  Medication compliance during a smoking cessation clinical trial: a brief intervention using MEMS feedback.

Authors:  Joy M Schmitz; Shelly L Sayre; Angela L Stotts; Jennifer Rothfleisch; Marc E Mooney
Journal:  J Behav Med       Date:  2005-04

Review 2.  What do you do when the blood pressure is up? An approach to the known hypertensive who has an elevated blood pressure.

Authors:  R L Schiff; M H Cohen; A Balson
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

Review 3.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 4.  The electronic medication event monitor. Lessons for pharmacotherapy.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

5.  An analysis of the quality of research reports in the Journal of General Internal Medicine.

Authors:  G S Cooper; L Zangwill
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

Review 6.  Patient compliance and medical research: issues in methodology.

Authors:  J Melnikow; C Kiefe
Journal:  J Gen Intern Med       Date:  1994-02       Impact factor: 5.128

7.  Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring.

Authors:  W Kruse; T Nikolaus; J Rampmaier; E Weber; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure.

Authors:  Wanzhu Tu; Andrew B Morris; Jingjin Li; Jingwei Wu; James Young; D Craig Brater; Michael D Murray
Journal:  Clin Pharmacol Ther       Date:  2005-03       Impact factor: 6.875

9.  Gaps in cardiovascular medication taking: the tip of the iceberg.

Authors:  P Rudd; J Ramesh; C Bryant-Kosling; D Guerrero
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

Review 10.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.